Delivery Order SPE2DB22D3004-SPE2DB24FQP55

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $6,139.14 firm fixed-price Delivery Order is for the supply of Repatha (evolocumab) 140 mg/mL SureClick injectors. The contract has a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick autoinjectors. The $1,126.44 fixed-price delivery order has a completion date of November 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) by the Defense Logistics Agency (DLA) is for the delivery of Repatha (evolocumab) 140 mg/mL SureClick injectors. The $2,004.37 firm fixed price delivery order is not set aside and has an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000,...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/ml SureClick medication. The contract has a ceiling value of $1,757.74 and an ultimate completion date of June 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Repatha 140 mg/ml SureClick injection medication. The contract is a Delivery Order with a Firm Fixed Price of $1,355.76 and an ultimate completion date of June 11, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,777.43 firm-fixed-price contract is for the supply of Repatha (evolocumab) 140mg/ml SureClick injectors. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order falls under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick injection medication. The $1,016.82 firm fixed price delivery order has a completion date of September 14, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick Autoinjector. The contract, valued at $3,709.88, is a firm-fixed-price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of Repatha, a 140 mg/ml SureClick injection, to the U.S. government. The $1,355.76 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of July 5, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the provision of Repatha (evolocumab) injection medication. The contract, valued at $1,401.56, is a delivery order with a firm fixed price. It has an ultimate completion date of July 15, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQP55
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Repatha (evolocumab) 140 mg/mL SureClick injectable medication. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,658.54 and a period of performance through June 4, 2024. Amerisourcebergen, through its Corporate Office division, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025 to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide in support of the Department of Defense. This specific Delivery Order award is not designated as a set-aside contract.

Generated 9/2/24, 3:29 PM